206 related articles for article (PubMed ID: 18602242)
1. Communicating side effect risks in a tamoxifen prophylaxis decision aid: the debiasing influence of pictographs.
Zikmund-Fisher BJ; Ubel PA; Smith DM; Derry HA; McClure JB; Stark A; Pitsch RK; Fagerlin A
Patient Educ Couns; 2008 Nov; 73(2):209-14. PubMed ID: 18602242
[TBL] [Abstract][Full Text] [Related]
2. Women's decisions regarding tamoxifen for breast cancer prevention: responses to a tailored decision aid.
Fagerlin A; Zikmund-Fisher BJ; Nair V; Derry HA; McClure JB; Greene S; Stark A; Hensley Alford S; Lantz P; Hayes DF; Wiese C; Claud Zweig S; Pitsch R; Jankovic A; Ubel PA
Breast Cancer Res Treat; 2010 Feb; 119(3):613-20. PubMed ID: 19908143
[TBL] [Abstract][Full Text] [Related]
3. A demonstration of ''less can be more'' in risk graphics.
Zikmund-Fisher BJ; Fagerlin A; Ubel PA
Med Decis Making; 2010; 30(6):661-71. PubMed ID: 20375419
[TBL] [Abstract][Full Text] [Related]
4. Testing whether decision aids introduce cognitive biases: results of a randomized trial.
Ubel PA; Smith DM; Zikmund-Fisher BJ; Derry HA; McClure J; Stark A; Wiese C; Greene S; Jankovic A; Fagerlin A
Patient Educ Couns; 2010 Aug; 80(2):158-63. PubMed ID: 20004545
[TBL] [Abstract][Full Text] [Related]
5. Communicating risk information: the influence of graphical display format on quantitative information perception-Accuracy, comprehension and preferences.
Price M; Cameron R; Butow P
Patient Educ Couns; 2007 Dec; 69(1-3):121-8. PubMed ID: 17905553
[TBL] [Abstract][Full Text] [Related]
6. Does Animation Improve Comprehension of Risk Information in Patients with Low Health Literacy? A Randomized Trial.
Housten AJ; Kamath GR; Bevers TB; Cantor SB; Dixon N; Hite A; Kallen MA; Leal VB; Li L; Volk RJ
Med Decis Making; 2020 Jan; 40(1):17-28. PubMed ID: 31795820
[No Abstract] [Full Text] [Related]
7. The impact of numeracy on verbatim knowledge of the longitudinal risk for prostate cancer recurrence following radiation therapy.
Hamstra DA; Johnson SB; Daignault S; Zikmund-Fisher BJ; Taylor JM; Larkin K; Wood A; Fagerlin A
Med Decis Making; 2015 Jan; 35(1):27-36. PubMed ID: 25277673
[TBL] [Abstract][Full Text] [Related]
8. The impact of the format of graphical presentation on health-related knowledge and treatment choices.
Hawley ST; Zikmund-Fisher B; Ubel P; Jancovic A; Lucas T; Fagerlin A
Patient Educ Couns; 2008 Dec; 73(3):448-55. PubMed ID: 18755566
[TBL] [Abstract][Full Text] [Related]
9. Results from a randomized trial of a web-based, tailored decision aid for women at high risk for breast cancer.
Banegas MP; McClure JB; Barlow WE; Ubel PA; Smith DM; Zikmund-Fisher BJ; Greene SM; Fagerlin A
Patient Educ Couns; 2013 Jun; 91(3):364-71. PubMed ID: 23395006
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of risk communication in a mammography patient decision aid.
Klein KA; Watson L; Ash JS; Eden KB
Patient Educ Couns; 2016 Jul; 99(7):1240-1248. PubMed ID: 26965020
[TBL] [Abstract][Full Text] [Related]
11. Preferences of Women Evaluating Risks of Tamoxifen (POWER) study of preferences for tamoxifen for breast cancer risk reduction.
Melnikow J; Paterniti D; Azari R; Kuenneth C; Birch S; Kuppermann M; Nuovo J; Keyzer J; Henderson S
Cancer; 2005 May; 103(10):1996-2005. PubMed ID: 15825209
[TBL] [Abstract][Full Text] [Related]
12. Knowledge of Potential Harms and Benefits of Tamoxifen among Women Considering Breast Cancer Preventive Therapy.
Thorneloe RJ; Hall LH; Walter FM; Side L; Lloyd KE; Smith SG;
Cancer Prev Res (Phila); 2020 Apr; 13(4):411-422. PubMed ID: 31988145
[TBL] [Abstract][Full Text] [Related]
13. The effect of format on parents' understanding of the risks and benefits of clinical research: a comparison between text, tables, and graphics.
Tait AR; Voepel-Lewis T; Zikmund-Fisher BJ; Fagerlin A
J Health Commun; 2010 Jul; 15(5):487-501. PubMed ID: 20677054
[TBL] [Abstract][Full Text] [Related]
14. Assessment of Breast Cancer Patients' Knowledge and Decisional Conflict Regarding Tamoxifen Use.
Kim SI; Lee Y; Son Y; Jun SY; Yun S; Bae HS; Lim MC; Jung SY; Joo J; Lee ES
J Korean Med Sci; 2015 Nov; 30(11):1604-10. PubMed ID: 26539004
[TBL] [Abstract][Full Text] [Related]
15. Communicating tailored risk information of cancer treatment side effects: Only words or also numbers?
Vromans RD; Pauws SC; Bol N; van de Poll-Franse LV; Krahmer EJ
BMC Med Inform Decis Mak; 2020 Oct; 20(1):277. PubMed ID: 33109175
[TBL] [Abstract][Full Text] [Related]
16. Decision-making about tamoxifen in women at high risk for breast cancer: clinical and psychological factors.
Bober SL; Hoke LA; Duda RB; Regan MM; Tung NM
J Clin Oncol; 2004 Dec; 22(24):4951-7. PubMed ID: 15598980
[TBL] [Abstract][Full Text] [Related]
17. Breast cancer anxiety's associations with responses to a chemoprevention decision aid.
Dillard AJ; Scherer L; Ubel PA; Smith DM; Zikmund-Fisher BJ; McClure JB; Greene S; Stark A; Fagerlin A
Soc Sci Med; 2013 Jan; 77():13-9. PubMed ID: 23200299
[TBL] [Abstract][Full Text] [Related]
18. Communicating the risk of side effects to patients: an evaluation of UK regulatory recommendations.
Knapp P; Raynor DK; Woolf E; Gardner PH; Carrigan N; McMillan B
Drug Saf; 2009; 32(10):837-49. PubMed ID: 19722727
[TBL] [Abstract][Full Text] [Related]
19. Assessment of pictographs developed through a participatory design process using an online survey tool.
Kim H; Nakamura C; Zeng-Treitler Q
J Med Internet Res; 2009 Feb; 11(1):e5. PubMed ID: 19275981
[TBL] [Abstract][Full Text] [Related]
20. Benefits and harms of selective oestrogen receptor modulators (SERMs) to reduce breast cancer risk: a cross-sectional study of methods to communicate risk in primary care.
McIntosh JG; Minshall J; Saya S; Bickerstaffe A; Hewabandu N; Qama A; Emery JD
Br J Gen Pract; 2019 Dec; 69(689):e836-e842. PubMed ID: 31636127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
